Drug Type lncRNA |
Synonyms Long Non-Coding RNA inhibitors- HAYA Therapeutics, Obesity and Related Metabolic Conditions(Haya Therapeutics) |
Target |
Mechanism RIPK1 inhibitors(Receptor-interacting serine/threonine-protein kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Discovery | UY | 04 Sep 2024 | |
Obesity | Discovery | CH | HAYA Therapeutics SAStartup | 04 Sep 2024 |
Squamous Cell Neoplasms | Discovery | CH | 01 May 2022 |